Clinical Trials Logo
  1. Home
  2. Breast Neoplasm Malignant Female
  3. NCT04198727

Study of the Impact of DPD Activity on the Efficacy of Capecitabine — DPDMAX  

Breast Neoplasm Malignant Female Clinical Trial

Official title:
Study of the Impact of DPD Activity on the Efficacy of Capecitabine

Clinical Trial Summary

This study evaluates the Impact of DihydroPyrimidine Dehydrogenase (DPD) activity on the efficacy of Capecitabine in patients with metastatic breast cancer. The DPD phenotype before the initiation of treatment will be assess and then the patient will be follow up during the treatment with Capecitabine up to 24 month.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04198727
Study type Interventional
Source Centre Antoine Lacassagne
Contact Christine LOVERA
Phone +33 492031618
Email christine.lovera@nice.unicancer.fr
Status Recruiting
Phase N/A
Start date July 20, 2020
Completion date April 2026
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05941299 - Clinical Trial to Demonstrate the Safety and Performance of REGENERA Breast Implant in 40-70 Years Old Women Affected by Malignant Breast Lesion Treated by Lumpectomy N/A
Completed NCT04348955 - Interest of Touch-massage in Hospital Day Care
Completed NCT05812326 - PD-1 Knockout Anti-MUC1 CAR-T Cells in the Treatment of Advanced Breast Cancer Phase 1/Phase 2
Recruiting NCT04424732 - SBRT for Breast Cancer Oligometastases N/A
Completed NCT03109080 - Olaparib & Radiation Therapy for Patients Triple Negative Breast Cancer (TNBC) Phase 1
Completed NCT03525990 - Study Evaluating the Impact of Electronic Surveys on Patient-physician Communication and Quality of Life in Breast Cancer Patients N/A
Recruiting NCT04289805 - Controlled Ovarian Stimulation in Newly Diagnosed Breast Cancer PatiEnts (fAMHOPE) Phase 4
Available NCT05134922 - Expanded Access Protocol for Subjects Previously Treated With Gedatolisib in B2151009